Gene · 5900
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development. | J Biol Chem | 2023 | 37100284 | PubTator, text mining | PubMed |
| The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival. | Pathophysiology | 2023 | 37092523 | PubTator, text mining | PubMed |
| Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19. | Nat Commun | 2023 | 37087523 | PubTator, text mining | PubMed |
| Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway. | Oncogene | 2023 | 37029300 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Newly developed 3D in vitro models to study tumor-immune interaction. | J Exp Clin Cancer Res | 2023 | 37016422 | PubTator, text mining | PubMed |
| Research Progress with Membrane Shielding Materials for Electromagnetic/Radiation Contamination. | Membranes (Basel) | 2023 | 36984702 | PubTator, text mining | PubMed |
| Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg. | Ther Adv Med Oncol | 2023 | 36950276 | PubTator, text mining | PubMed |
| Spontaneously evolved progenitor niches escape Yap oncogene addiction in advanced pancreatic ductal adenocarcinomas. | Nat Commun | 2023 | 36922511 | PubTator, text mining | PubMed |
| Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target. | Int J Mol Sci | 2023 | 36902091 | PubTator, text mining | PubMed |
| KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions. | Cells | 2023 | 36899885 | PubTator, text mining | PubMed |
| Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review. | Transl Lung Cancer Res | 2023 | 36895930 | PubTator, text mining | PubMed |
| Analysis of context-specific KRAS-effector (sub)complexes in Caco-2 cells. | Life Sci Alliance | 2023 | 36894174 | PubTator, text mining | PubMed |
| Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers. | iScience | 2023 | 36852277 | PubTator, text mining | PubMed |
| The Roles of TRAF3 in Immune Responses. | Dis Markers | 2023 | 36845015 | PubTator, text mining | PubMed |
| Interactions between β-arrestin proteins and the cytoskeletal system, and their relevance to neurodegenerative disorders. | Front Endocrinol (Lausanne) | 2023 | 36843600 | PubTator, text mining | PubMed |
| Design of Functional RGD Peptide-Based Biomaterials for Tissue Engineering. | Pharmaceutics | 2023 | 36839667 | PubTator, text mining | PubMed |
| Co-Expression Analysis of Airway Epithelial Transcriptome in Asthma Patients with Eosinophilic vs. Non-Eosinophilic Airway Infiltration. | Int J Mol Sci | 2023 | 36835202 | PubTator, text mining | PubMed |
| Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. | World J Gastroenterol | 2023 | 36816628 | PubTator, text mining | PubMed |
| Recent advances in peptide-based therapeutic strategies for breast cancer treatment. | Front Pharmacol | 2023 | 36794282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5900/papers?page=6